UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity

Clinical cancer research, 2016-10, Vol.22 (20), p.5130-5140

2016

Volltextzugriff (PDF)

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Annals of oncology, 2017-02, Vol.28 (2), p.270-277

2017

Volltextzugriff (PDF)

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Journal of clinical oncology, 2016-03, Vol.34 (7), p.661-668

2016

Volltextzugriff (PDF)

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2016-12, Vol.34 (34), p.4079-4085

2016

Volltextzugriff (PDF)

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Science (American Association for the Advancement of Science), 2008-12, Vol.322 (5908), p.1695-1699

2008

Volltextzugriff (PDF)

Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.22-27

2020

Volltextzugriff (PDF)

The metastatic pattern of intestinal and diffuse type gastric carcinoma – A Dutch national cohort study

Cancer epidemiology, 2020-12, Vol.69, p.101846-101846, Article 101846

2020

Volltextzugriff (PDF)

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Breast cancer research and treatment, 2012-09, Vol.135 (2), p.415-432

2012

Volltextzugriff (PDF)

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

Bone marrow transplantation (Basingstoke), 2012-10, Vol.47 (10), p.1287-1293

2012

Volltextzugriff (PDF)

Ultrasound of the joints and entheses in healthy children

Pediatric radiology, 2015-08, Vol.45 (9), p.1344-1354

2015

Volltextzugriff (PDF)

Size of testes, ovaries, uterus and breast buds by ultrasound in healthy full-term neonates ages 0–3 days

Pediatric radiology, 2016-12, Vol.46 (13), p.1837-1847

2016

Volltextzugriff (PDF)

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

International journal of radiation oncology, biology, physics, 2004-12, Vol.60 (5), p.1502-1509

2004

Volltextzugriff (PDF)

TMPRSS2―ERG-Mediated Feed-Forward Regulation of Wild-Type ERG in Human Prostate Cancers

Cancer research (Chicago, Ill.), 2011-08, Vol.71 (16), p.5387-5392

2011

Volltextzugriff (PDF)

Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers

Cancer causes & control, 2011-02, Vol.22 (2), p.167-180

2011

Volltextzugriff (PDF)

Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2011-09, Vol.16 (9), p.1307-1315

2011

Volltextzugriff (PDF)

Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication

International journal of radiation oncology, biology, physics, 2002-09, Vol.54 (1), p.156-162

2002

Volltextzugriff (PDF)

Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study

Carcinogenesis (New York), 2004-09, Vol.25 (9), p.1593-1598

2004

Volltextzugriff (PDF)

Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease

International journal of radiation oncology, biology, physics, 2003-05, Vol.56 (1), p.229-234

2003

Volltextzugriff (PDF)

Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description

Radiotherapy and oncology, 2002-04, Vol.63 (1), p.41-45

2002

Volltextzugriff (PDF)

Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease

International journal of radiation oncology, biology, physics, 2005-07, Vol.62 (4), p.1150-1156

2005

Volltextzugriff (PDF)

Unique features of breast cancer in Taiwan

Breast cancer research and treatment, 2000-10, Vol.63 (3), p.213-223

2000

Volltextzugriff (PDF)

Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization

International journal of cancer, 2001-08, Vol.96 (4), p.243-252

2001

Volltextzugriff (PDF)

Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients

Cancer, 2004-11, Vol.101 (9), p.2126-2133

2004

Volltextzugriff (PDF)

Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy

International journal of radiation oncology, biology, physics, 2002-06, Vol.53 (2), p.344-352

2002

Volltextzugriff (PDF)

1 – 25 von 1.060

Suche als RSS-Feed

Aktive Filter

SpracheTürkisch

ThemaPhysics

ThemaMale

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.016)
Mit Volltextzugriff
(1.001)

Publikationsform

Artikel
(1.060)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.056)
Life Sciences & Biomedicine
(1.030)
Humans
(1.028)
Female
(898)
Middle Aged
(783)
Aged
(725)
Adult
(574)
Aged, 80 And Over
(371)
Lung Neoplasms - Drug Therapy
(363)
Mutation
(321)
Lung Neoplasms - Genetics
(310)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(302)
Treatment Outcome
(264)
Retrospective Studies
(256)
Carcinoma, Non-Small-Cell Lung - Genetics
(252)
Lung Neoplasms - Pathology
(245)
Erbb Receptors - Genetics
(241)
Lung Cancer
(228)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(57)
International Journal Of Radiation Oncology, Biology, Physics
(54)
Bmc Cancer
(41)
Clinical Lung Cancer
(34)
Cancer
(32)
Thoracic Cancer
(32)
Radiation Oncology
(30)
British Journal Of Cancer
(28)
Journal Of Thoracic Oncology
(28)
Plos One
(25)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer

The metastatic pattern of intestinal and diffuse type gastric carcinoma – A Dutch national cohort study

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

Ultrasound of the joints and entheses in healthy children

Size of testes, ovaries, uterus and breast buds by ultrasound in healthy full-term neonates ages 0–3 days

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

TMPRSS2―ERG-Mediated Feed-Forward Regulation of Wild-Type ERG in Human Prostate Cancers

Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers

Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non‐Small Cell Lung Cancer

Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication

Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study

Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease

Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description

Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease

Unique features of breast cancer in Taiwan

Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization

Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients

Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy

Aktive Filter

Suchergebnisse filtern